Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2024/02/063165
CTRI/2024/02/063165Not yet recruitingPhase 3

Efficacy Of Loha Rasayana and Vyoshadi Saktu On Atherogenic Index Of Plasma (AIP) In Patients Of Metabolic Syndrome - An Open Labelled Randomized Comparative Clinical Trial. - METS

All India Institute of Ayurveda0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Patients fulfilling the Diagnostic criteria of Metabolic Syndrome.
  • •Patients fit for Virechana Karma.

Exclusion Criteria

  • •Age group below 30 years and above 60 years.
  • •Patients not fulfilling the Diagnostic criteria of Metabolic Syndrome

Investigators

Similar Trials

Completed
Phase 3
Ayurvedic management of Migraine with the help of Laghu Sutashekhara Rasa Tablet and Nasal drop of Brihata Dashmoola Taila
CTRI/2022/01/039319ITRA Jamnagar44
Not yet recruiting
Phase 3
Managing Migraine through Ayurveda with the intake of Tablet Laghu Sutashekhar Rasa and Brihat Dashmoola Taila as Nasal drops.
CTRI/2023/04/051278ITRA Jamnagar
Not yet recruiting
Phase 2
Ayurvedic management of Migraine by using Laghu Sutashekhara rasa(orally) with and without Brihata Dashmoola taila nasya(nasal drops).
CTRI/2024/03/064422Institute of Teaching and Research in Ayurveda Jamnagar
Not yet recruiting
Phase 3
Role of Ayurveda in Hypothyroidism
CTRI/2023/04/051517Institute of Teaching and Research in Ayurveda Jamnagar 361008 GUJARAT
Not yet recruiting
Phase 3
snigdha (unctuous) and rooksha (dry)virechana in healthy individuals
CTRI/2022/03/041436Institute of teaching and Research in Ayurveda Jamnagar